CN114344212A - Moisturizing, firming and soothing skin care composition and preparation method thereof - Google Patents
Moisturizing, firming and soothing skin care composition and preparation method thereof Download PDFInfo
- Publication number
- CN114344212A CN114344212A CN202111649120.0A CN202111649120A CN114344212A CN 114344212 A CN114344212 A CN 114344212A CN 202111649120 A CN202111649120 A CN 202111649120A CN 114344212 A CN114344212 A CN 114344212A
- Authority
- CN
- China
- Prior art keywords
- moisturizing
- skin care
- care composition
- tightening
- soothing skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 241000208680 Hamamelis mollis Species 0.000 claims abstract description 20
- 239000000047 product Substances 0.000 claims abstract description 20
- 229940118846 witch hazel Drugs 0.000 claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 16
- 230000004151 fermentation Effects 0.000 claims abstract description 16
- 239000000706 filtrate Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 11
- 230000009286 beneficial effect Effects 0.000 claims abstract description 11
- 150000003672 ureas Chemical class 0.000 claims abstract description 7
- 102000008186 Collagen Human genes 0.000 claims abstract description 6
- 108010035532 Collagen Proteins 0.000 claims abstract description 6
- 229920001436 collagen Polymers 0.000 claims abstract description 6
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 6
- 229920001503 Glucan Polymers 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 13
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical group NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- 239000002738 chelating agent Substances 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- 229920002125 Sokalan® Polymers 0.000 claims description 5
- 229960000458 allantoin Drugs 0.000 claims description 5
- 229920001222 biopolymer Polymers 0.000 claims description 5
- 229960001631 carbomer Drugs 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 229920002307 Dextran Polymers 0.000 claims description 4
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- -1 dextran aldehyde Chemical class 0.000 claims description 2
- 229940031575 hydroxyethyl urea Drugs 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 229920006158 high molecular weight polymer Polymers 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 62
- 230000000694 effects Effects 0.000 abstract description 11
- 210000002950 fibroblast Anatomy 0.000 abstract description 4
- 102000004363 Aquaporin 3 Human genes 0.000 abstract description 2
- 108090000991 Aquaporin 3 Proteins 0.000 abstract description 2
- 206010013786 Dry skin Diseases 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 230000037336 dry skin Effects 0.000 abstract description 2
- 230000036571 hydration Effects 0.000 abstract description 2
- 238000006703 hydration reaction Methods 0.000 abstract description 2
- 230000035755 proliferation Effects 0.000 abstract description 2
- 210000000434 stratum corneum Anatomy 0.000 abstract description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000007788 liquid Substances 0.000 description 9
- 229940015975 1,2-hexanediol Drugs 0.000 description 7
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 7
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 6
- 229940078492 ppg-17 Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 239000004288 Sodium dehydroacetate Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229940079839 sodium dehydroacetate Drugs 0.000 description 4
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 4
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 3
- 241000208681 Hamamelis virginiana Species 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- ZJBHFQKJEBGFNL-UHFFFAOYSA-N methylsilanetriol Chemical compound C[Si](O)(O)O ZJBHFQKJEBGFNL-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229940089952 silanetriol Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229940084760 glycyrrhiza inflata root extract Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000141 poly(maleic anhydride) Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229940084750 sophora flavescens root extract Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention relates to A61K8, in particular to a moisturizing, tightening and relieving skin care composition and a preparation method thereof. The raw materials of the moisturizing, firming and soothing skin care composition comprise polyhydric alcohol, glucan derivatives, urea derivatives, witch hazel shrub extracts and beneficial bacterium fermentation product filtrate. The skin care composition obtained by the invention has good moisturizing capability, can recover the expression of aquaporin-3 and provide the optimal hydration force for skin, thereby improving the water content of stratum corneum, reducing the percutaneous water loss, maintaining the normal moisture of the skin, relieving the influence of the outside on dry skin and reducing the sensitive chain reaction caused by dryness. In addition, the composition can tighten skin, restore fibroblast proliferation and activity, promote fibroblast to generate more collagen, and make skin more firm and elastic.
Description
Technical Field
The invention relates to A61K8, in particular to a moisturizing, tightening and relieving skin care composition and a preparation method thereof.
Background
The environmental temperature is reduced, the skin layer of the organism can not generate a regulating mechanism in time, the activity of the sebaceous glands is reduced, the moisture and the grease of the skin are reduced to a certain degree, and the skin becomes tight and even wrinkles. The negative effects of this regulation mechanism become more pronounced with age and the degree of sagging of the skin is increased by the loss of collagen, for which reason people often improve this condition by using skin care products.
Patent No. CN104013549B provides a skin care product containing chinese gold silk extract, which is added with active ingredient chinese gold silk extract to improve skin softness, and has low irritation to skin and metabolism promotion effect.
However, these skin care products often have difficulty in maintaining their own activity for a long period of time, often develop bacteria after a period of time, and have a challenge in heat resistance and cold resistance, thereby failing to exert their original effects when applied to the skin.
Disclosure of Invention
In order to solve the above problems, the present invention provides, in a first aspect, a moisturizing, firming and soothing skin care composition, which comprises a polyol, a glucan derivative, a urea derivative, a witch hazel shrub extract, and a filtrate of a fermentation product of beneficial bacteria as raw materials.
As a preferable technical scheme of the invention, the raw materials of the moisturizing, firming and soothing skin care composition further comprise a biological high polymer, a carboxylic acid-based high polymer and a chelating agent.
As a preferred technical scheme, the polyalcohol is selected from one or more of glycerol, butanediol and polyethylene glycol.
As a preferable technical scheme of the invention, the dextran derivative is selected from one or more of sodium hyaluronate, dextran aldehyde and dextran acid.
In a preferred embodiment of the present invention, the urea derivative is allantoin and/or hydroxyethyl urea.
In a preferred embodiment of the present invention, the biopolymer is selected from one or more of cellulose, collagen, and xanthan gum.
As a preferable technical scheme of the invention, the acid high molecular polymer is carbomer and/or polyvinyl acid.
Preferably, the chelating agent is selected from one or more of disodium EDTA, hydrolyzed polymaleic anhydride, and citric acid chelating agent.
Preferably, the moisturizing, firming and soothing skin care composition further comprises butanediol, p-hydroxyacetophenone and 1, 2-hexanediol as raw materials.
As a preferred technical scheme of the invention, the witch hazel shrub extract is a witch hazel extract and/or witch hazel water.
As a preferable technical scheme, the beneficial bacteria fermentation product filtrate is a split yeast fermentation product filtrate and/or a galactose yeast-like bacteria fermentation product filtrate.
Preferably, the raw materials of the moisturizing, firming and soothing skin care composition further comprise deionized water, butanediol, scutellaria root extract, sophora flavescens root extract, glycyrrhiza inflate root extract, triethanolamine, PEG/PPG-17/6 copolymer, methyl propylene glycol, hyaluronic acid, silantriol, citric acid, propylene glycol, sodium dehydroacetate, 1, 2-hexanediol and p-hydroxyacetophenone.
PEG/PPG-17/6 copolymer
PEG/PPG-17/6 copolymer is widely used in cosmetics, and is often used as a surfactant and emulsifier. The PEG/PPG-17/6 copolymer in the hydrophilic phase system has good anti-sticking performance, can be used in a skin care formula together with polyalcohol and humectant, has low skin irritation, basically has no special odor, and brings good use feeling.
Preferably, the raw materials of the moisturizing, firming and soothing skin care composition further comprise essence and PEG-40 hydrogenated castor oil.
PEG-40 hydrogenated Castor oil
The PEG-40 hydrogenated castor oil is derived from natural plants, can uniformly disperse oil substances such as essential oil, essence and the like into a water phase, is a high-efficiency solubilizing surfactant, and is beneficial to forming a transparent and stable solution system.
The applicant finds that in experiments, a certain amount of the yeast fermentation product filtrate and the specific witch hazel shrub extract are added into the skin care composition, so that the skin care composition is beneficial to moisturizing and tightening of human skin, can still exert the original effect after being placed for a long time, and does not generate peculiar smell. The reason is probably that the metabolites in the secondary fission yeast fermentation product filtrate are collagen, polypeptide, mineral substances and organic acid, and have intermolecular action with an active group on the witch hazel bush plant extract, so that the intermolecular binding force is increased, and simultaneously, the metabolites are connected with a carbonyl group on an allantoin derivative in a system through hydrogen bonds, and all substances have synergistic action to form a stable dispersion system, so that the stability of the composition system is remarkably improved, the original substance performance can be kept after the composition is placed for a long time, and peculiar smell caused by other impurities can not be generated, so that the composition can keep better sensory experience when in use.
Preferably, the phase A raw materials comprise the following components in parts by weight: 0.01-0.05 part of xanthan gum, 0.1-0.3 part of allantoin, 0.01-0.5 part of carbomer, 1-10 parts of glycerol, 0.005-0.2 part of sodium hyaluronate and 0.002-0.03 part of EDTA disodium.
Preferably, the phase B raw materials comprise the following components in parts by weight: 1-10 parts of butanediol, 0.2-0.8 part of p-hydroxyacetophenone and 0.2-0.8 part of 1, 2-hexanediol.
Preferably, the phase C raw materials comprise the following components in parts by weight: 47-63 parts of deionized water, 30-40 parts of butanediol, 3-5 parts of radix scutellariae extract, 2-4 parts of radix sophorae flavescentis extract, 0.005-1 part of liquorice root extract, 0.01-0.5 part of triethanolamine, 0.1-5 parts of PEG/PPG-17/6 copolymer, 15-22 parts of methyl propylene glycol, 0.20-0.40 part of hyaluronic acid, 0.15-0.35 part of silanetriol, 0.15-0.32 part of citric acid, 18-21 parts of propylene glycol, 5.21-6.13 parts of witch hazel extract, 0.01-0.05 part of sodium dehydroacetate, 0.2-5 parts of witch hazel water, 0.30-0.012 part of methyl hydroxybenzoate, 0.2-5 parts of yeast fermentation product filtrate, 0.3-0.6 part of 1, 2-hexanediol and 0.0001-0.5 part of p-hydroxyacetophenone.
Preferably, the phase D raw materials comprise the following components in parts by weight: 0.001-0.2 part of essence and 0.004-0.8 part of PEG-40 hydrogenated castor oil.
In a second aspect, the present invention provides a method for preparing a moisturizing, firming, soothing skin care composition, comprising the steps of: (1) prefabricating; (2) and (5) cooling after mixing.
The method comprises the following concrete steps: mixing the raw materials of the phase B, and stirring for 20min to obtain a phase B prefabricated liquid; mixing the raw materials of the phase B, and stirring for 20min to obtain a phase C mixture; mixing the raw materials of the phase D, and stirring for 20min to obtain a phase D prefabricated liquid.
The concrete steps of cooling after mixing are as follows: mixing the raw materials of phase A, stirring for 10min, heating to 80-85 deg.C, and stirring for 1.0-1.5 h. Naturally cooling to 45 deg.C, adding the B-phase prefabricated liquid, adding the C-phase mixture and the D-phase prefabricated liquid, and stirring for 0.5-1h to obtain the skin care composition.
Compared with the prior art, the invention has the following beneficial effects:
(1) the skin care composition obtained by the invention has good moisturizing capability, can recover the expression of aquaporin-3 and provide the optimal hydration force for skin, thereby improving the water content of stratum corneum, reducing the percutaneous water loss, maintaining the normal moisture of the skin, relieving the influence of the outside on dry skin and reducing the sensitive chain reaction caused by dryness.
(2) The skin care composition obtained by the invention can tighten skin, recover fibroblast proliferation and activity, and promote fibroblasts to generate more collagen, so that the skin becomes more tight and elastic.
(3) The skin care composition obtained by the invention can keep self activity for a long time, does not generate bacteria after being placed for a period of time, has good heat resistance and cold resistance, and can exert the original effect when being used on skin.
(4) The skin care composition provided by the invention has no peculiar smell and good use experience.
(5) The invention can be widely applied to face cleaning, skin care and body beautifying products, effectively improves the skin condition, is mild and non-irritating, and has certain relieving effect.
Detailed Description
Examples
The compositions of the examples were prepared from commercially available materials, including Glycerol CAS No. 56-81-5, EDTA disodium CAS No. 2017-8-23, Scutellaria baicalensis Georgi root extract, Sophora flavescens ait root extract, Glycyrrhiza inflata root extract, propylene glycol CAS No. 57-55-6, Hamamelis virginiana extract, Hamamelis water AMERICAN DISTILLING INC, and essence, Ostre rosea, Otsukura.
Example 1
The embodiment provides a moisturizing, firming and soothing skin care composition, which is prepared from the raw materials of an A phase, a B phase, a C phase and a D phase.
The phase A comprises the following raw materials in parts by weight: 0.02 part of biopolymer (specifically xanthan gum), 0.2 part of urea derivative (specifically allantoin), 0.03 part of acid high-molecular polymer (specifically carbomer), 2 parts of polyalcohol (specifically glycerol), 0.005 part of glucan derivative (specifically sodium hyaluronate) and 0.002 part of chelating agent (specifically EDTA disodium).
The phase B raw materials comprise: 5 parts of butanediol, 0.3 part of p-hydroxyacetophenone and 0.3 part of 1, 2-hexanediol.
The C phase raw material comprises: 50 parts of deionized water, 35 parts of butanediol, 3 parts of radix scutellariae extract, 2 parts of radix sophorae flavescentis extract, 0.005 part of glycyrrhiza inflate, 0.2 part of triethanolamine, 1 part of PEG/PPG-17/6 copolymer, 15 parts of methyl propylene glycol, 0.20 part of hyaluronic acid, 0.15 part of silanetriol, 0.15 part of citric acid, 18 parts of propylene glycol, 6.71 parts of witch hazel bush extract (comprising 5.21 parts of witch hazel extract and 1.5 parts of witch hazel water), 0.01 part of sodium dehydroacetate, 0.12 part of methyl hydroxybenzoate, 0.8 part of beneficial bacterium fermentation product filtrate (specifically, schizosaccharomyces cerevisiae fermentation product filtrate), 0.3 part of 1, 2-hexanediol and 0.5 part of p-hydroxyacetophenone.
The phase D raw material comprises: 0.005 part of essence and 0.05 part of PEG-40 hydrogenated castor oil.
The present example also provides a method of preparing a moisturizing, firming, soothing skin care composition comprising the steps of: (1) prefabricating; (2) and (5) cooling after mixing.
The method comprises the following concrete steps: mixing the raw materials of the phase B, and stirring for 20min to obtain a phase B prefabricated liquid; mixing the raw materials of the phase B, and stirring for 20min to obtain a phase C mixture; mixing the raw materials of the phase D, and stirring for 20min to obtain a phase D prefabricated liquid.
The concrete steps of cooling after mixing are as follows: mixing the raw materials of phase A, stirring for 10min, heating to 80 deg.C, and stirring for 1.0 h. Naturally cooling to 45 deg.C, adding the B-phase prefabricated liquid, adding the C-phase mixture and the D-phase prefabricated liquid, and stirring for 1 hr to obtain the skin care composition.
Example 2
This example provides a moisturizing, firming, soothing skin care composition, which differs from example 1 in 6.13 parts by weight of witch hazel extract.
This example also provides a method of making a moisturizing, firming, soothing skin care composition, similar to that of example 1.
Example 3
This example provides a moisturizing, firming, soothing skin care composition that differs from example 1 in that 6.61 parts by weight of witch hazel shrub extract (including 4.21 parts of witch hazel extract and 2.1 parts of witch hazel water).
This example also provides a method of making a moisturizing, firming, soothing skin care composition, similar to that of example 1.
Example 4
This example provides a moisturizing, firming, soothing skin care composition, which differs from example 1 in that, by weight, hamamelis virginiana extract 5.01 parts, hamamelis virginiana water 2 parts, sodium dehydroacetate 0.03 parts, methylparaben 0.11 parts, beneficial bacteria fermentation product filtrate (specifically, yeast bifida fermentation product filtrate) 0.05 parts, 1, 2-hexanediol 0.2 parts, and p-hydroxyacetophenone 0.4 parts.
This example also provides a method of making a moisturizing, firming, soothing skin care composition, similar to that of example 1.
Example 5
The embodiment provides a moisturizing, firming and soothing skin care composition, which is different from the embodiment 1 in that the phase A comprises the following raw materials in parts by weight: 0.005 part of biopolymer (specifically xanthan gum), 0.05 part of urea derivative (specifically allantoin), 0.02 part of acid high-molecular polymer (specifically carbomer), 1.8 parts of polyalcohol (specifically glycerol), 0.004 part of glucan derivative (specifically sodium hyaluronate), and 0.003 part of chelating agent (specifically disodium EDTA).
This example also provides a method of making a moisturizing, firming, soothing skin care composition, similar to that of example 1.
And (3) performance testing:
1. the moisturizing, firming and soothing skin care composition obtained in example 1 was tested according to QB/T2660 and the results are shown in Table 1:
TABLE 1
2. Sensory testing: the moisturizing, firming and soothing skin care compositions obtained in examples 1-5 were left at 25 ℃ for 24 hours and observed for appearance, with examples 1-3 being colorless liquids and examples 4 and 5 being slightly cloudy.
3. And (3) heat resistance test: the pH of the moisturizing, firming and soothing skin care compositions obtained in examples 1-5 were measured using a pH meter and maintained at 40 ℃ for 24 hours, and the pH was measured again, with the results shown in table 2:
TABLE 2
| Examples | pH value (before standing at 40 degree C) | pH value (after standing at 40 ℃ C.) |
| 1 | 6.7 | 6.7 |
| 2 | 6.4 | 6.4 |
| 3 | 6.6 | 6.6 |
| 4 | 6.3 | 6.7 |
| 5 | 5.9 | 6.4 |
4. Cold resistance test: the moisturizing, tightening and soothing skin care compositions obtained in examples 1 to 5 were measured for pH using a pH meter, maintained at 5 ℃ for 24 hours, and measured again for pH, with the results shown in table 3:
TABLE 3
| Examples | pH value (before standing at 5 degree C) | pH value (after standing at 5 ℃ C.) |
| 1 | 6.7 | 6.7 |
| 2 | 6.4 | 6.4 |
| 3 | 6.6 | 6.6 |
| 4 | 6.3 | 6.0 |
| 5 | 5.9 | 6.3 |
5. And (3) testing microorganisms: the moisturizing, tightening and soothing skin care compositions obtained in examples 1-3 were tested for staphylococcus aureus and pseudomonas aeruginosa according to the cosmetic safety specifications (2015 edition). None of the moisturizing, firming, soothing skin care compositions obtained in examples 1-3 detected staphylococcus aureus and pseudomonas aeruginosa.
6. Moisture retention test: the moisturizing, firming and soothing skin care compositions obtained in examples 1-3 have better moisturizing performance when applied to skin.
It can be seen that the moisturizing, firming and soothing skin care compositions obtained in examples 1-3 have good heat resistance and cold resistance, do not grow bacteria, are beneficial for long-term storage, and have good moisturizing properties when applied to the skin.
Claims (10)
1. The moisturizing, firming and soothing skin care composition is characterized in that raw materials of the moisturizing, firming and soothing skin care composition comprise polyhydric alcohol, glucan derivative, urea derivative, witch hazel shrub extract and beneficial bacterium fermentation product filtrate.
2. The moisturizing, tightening, soothing skin care composition according to claim 1, wherein the raw materials of the moisturizing, tightening, soothing skin care composition further comprise a biopolymer, an acid-based polymer, and a chelating agent.
3. The moisturizing, tightening, soothing skin care composition according to claim 2, wherein the polyol is selected from one or more of glycerin, butylene glycol, and polyethylene glycol.
4. The moisturizing, tightening, soothing skin care composition according to claim 2, wherein the dextran derivative is selected from one or more of sodium hyaluronate, dextran aldehyde, dextran acid.
5. The moisturizing, tightening, soothing skin care composition of claim 2, wherein the urea derivative is allantoin and/or hydroxyethyl urea.
6. The moisturizing, tightening, soothing skin care composition according to claim 2, wherein the biopolymer is selected from one or more of cellulose, collagen, xanthan gum.
7. The moisturizing, tightening, soothing skin care composition of claim 3, wherein the acid based high molecular weight polymer is carbomer and/or polyvinyl acid.
8. The moisturizing, tightening, soothing skin care composition of claim 3, wherein the witch hazel shrub extract is witch hazel extract and/or witch hazel water.
9. The moisturizing, tightening, soothing skin care composition of claim 3, wherein the beneficial bacteria fermentation product filtrate is a split yeast fermentation product filtrate and/or a galacto-yeast fermentation product filtrate.
10. A method of making a moisturizing, tightening, soothing skin care composition according to any of claims 1-9, comprising the steps of: (1) prefabricating; (2) and (5) cooling after mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111649120.0A CN114344212A (en) | 2021-12-30 | 2021-12-30 | Moisturizing, firming and soothing skin care composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111649120.0A CN114344212A (en) | 2021-12-30 | 2021-12-30 | Moisturizing, firming and soothing skin care composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114344212A true CN114344212A (en) | 2022-04-15 |
Family
ID=81103042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111649120.0A Pending CN114344212A (en) | 2021-12-30 | 2021-12-30 | Moisturizing, firming and soothing skin care composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114344212A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103462881A (en) * | 2013-10-10 | 2013-12-25 | 深圳市金因生物技术有限公司 | Composite capable of promoting skin micro-ecological balance and preparation method thereof |
| CN103976905A (en) * | 2014-05-29 | 2014-08-13 | 上海清轩生物科技有限公司 | Plant extract liquid mixture with antiphlogosis and antianaphylaxis effect |
| WO2015052082A1 (en) * | 2013-10-08 | 2015-04-16 | Basf Beauty Care Solutions France S.A.S. | Cosmetic or dermatological use of an extract of hamamelis virginiana |
| CN106074315A (en) * | 2016-08-24 | 2016-11-09 | 广东芭薇生物科技股份有限公司 | A kind of facial mask liquid with multiple skin-care effect and preparation method thereof |
| CN112076128A (en) * | 2020-09-30 | 2020-12-15 | 广州市爱百伊生物技术有限公司 | Anti-aging repairing day cream and preparation method thereof |
| WO2021003962A1 (en) * | 2019-07-11 | 2021-01-14 | 浙江康满家日用品有限公司 | Skincare composition for repairing skin, and preparation method therefor |
| CN113786378A (en) * | 2021-09-26 | 2021-12-14 | 湖北省麦诗特生物科技有限公司 | Toning lotion composition with effects of improving skin color and brightening skin and preparation method thereof |
| CN113786362A (en) * | 2021-09-26 | 2021-12-14 | 湖北省麦诗特生物科技有限公司 | Toning lotion composition with effects of relieving, balancing and protecting skin and preparation method thereof |
-
2021
- 2021-12-30 CN CN202111649120.0A patent/CN114344212A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015052082A1 (en) * | 2013-10-08 | 2015-04-16 | Basf Beauty Care Solutions France S.A.S. | Cosmetic or dermatological use of an extract of hamamelis virginiana |
| CN103462881A (en) * | 2013-10-10 | 2013-12-25 | 深圳市金因生物技术有限公司 | Composite capable of promoting skin micro-ecological balance and preparation method thereof |
| CN103976905A (en) * | 2014-05-29 | 2014-08-13 | 上海清轩生物科技有限公司 | Plant extract liquid mixture with antiphlogosis and antianaphylaxis effect |
| CN106074315A (en) * | 2016-08-24 | 2016-11-09 | 广东芭薇生物科技股份有限公司 | A kind of facial mask liquid with multiple skin-care effect and preparation method thereof |
| WO2021003962A1 (en) * | 2019-07-11 | 2021-01-14 | 浙江康满家日用品有限公司 | Skincare composition for repairing skin, and preparation method therefor |
| CN112076128A (en) * | 2020-09-30 | 2020-12-15 | 广州市爱百伊生物技术有限公司 | Anti-aging repairing day cream and preparation method thereof |
| CN113786378A (en) * | 2021-09-26 | 2021-12-14 | 湖北省麦诗特生物科技有限公司 | Toning lotion composition with effects of improving skin color and brightening skin and preparation method thereof |
| CN113786362A (en) * | 2021-09-26 | 2021-12-14 | 湖北省麦诗特生物科技有限公司 | Toning lotion composition with effects of relieving, balancing and protecting skin and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1690525A1 (en) | Gamma polyglutamic acid (gamma-pga, h form), gamma-polyglutamate hydrogels for use as super moisturizers in cosmetic and personal care products | |
| CN112353750A (en) | Hemp leaf soothing and repairing essence and preparation method thereof | |
| CN106619186B (en) | Preparation for protecting activity of superoxide dismutase and preparation method thereof | |
| CN113197836A (en) | Moisturizing, relieving, itching-relieving and skin-protecting cream and preparation method thereof | |
| CN109350579B (en) | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | |
| KR101100678B1 (en) | Cosmetic Composition comprising plant extracts | |
| CN113116755A (en) | Skin care composition for promoting penetration and preparation method and application thereof | |
| CN113893206A (en) | Soothing skin cream suitable for sensitive skin for infants and preparation method thereof | |
| CN114712275A (en) | Anti-wrinkle repair composition and preparation method thereof, and cosmetic and preparation method thereof | |
| CN111773174B (en) | Repairing cream and preparation method thereof | |
| CN112107724A (en) | Liquid dressing and preparation method thereof | |
| CN113181074A (en) | Composite folic acid anti-allergic and anti-irritation skin care composition and preparation method and application thereof | |
| CN112402308A (en) | Multi-effect relieving moisturizing lotion and preparation method thereof | |
| CN112402354A (en) | Moisturizing and moisture-preserving emulsion and preparation method thereof | |
| CN114344212A (en) | Moisturizing, firming and soothing skin care composition and preparation method thereof | |
| CN109453088B (en) | Whitening and firming cream, preparation method thereof and tyrosinase inhibitor | |
| KR20210072966A (en) | Nanocapsule composition for skin moisturizing or skin inflammatory improvement comprsing encapsulated centella and calamine | |
| KR20100066754A (en) | Cosmetic composition containing moisturizing complex for moisturizing the skin | |
| CN111035588A (en) | Plant extract soothing eye cream and preparation method thereof | |
| KR102061313B1 (en) | Barley bran and herb fermented extract and process for producing cosmetic products having an acne-improving effect containing an extract | |
| KR20220133136A (en) | Composition for improving acne skin comprising hemp seed extract and hemp seed oil | |
| CN114053186A (en) | Long-acting rose essence lotion capable of moisturizing and whitening skin and preparation method thereof | |
| CN113491664A (en) | Composition for quickly relieving pruritus as well as preparation method and application thereof | |
| CN112972323A (en) | Hemp leaf essence and preparation method thereof | |
| KR20090068397A (en) | Cosmetic composition with the effect of calming skins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |